Conference Coverage

Stephen Hanauer, MD, on the Past, Present, and Future of IBD Pharmacology

12/10/2021

Dr Hanauer reviews his keynote address from December 9 at Advances in Inflammatory Bowel Diseases 2021 on advances in pharmacology for the treatment of IBD from the advent of sulfasalazine to today’s biologics and small molecules.

Stephen Hanauer, MD, is the Clifford Joseph Clifford Joseph Barborka professor of medicine at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois.

Latest News

News

Assessing Transmural Healing and Response in Patients with Crohn's Disease

11/18/2024

The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.

The the modified Clermont score...

11/18/2024

Advances in Inflammatory Bowel Disease Network

News

Impact of Concomitant Medications on Advanced Therapies for Ulcerative Colitis

11/12/2024

Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.

Most concomitant medications do...

11/12/2024

Advances in Inflammatory Bowel Disease Network

News

MRE or IUS for Crohn’s Disease Imaging?

11/06/2024

Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.

Investigators found patients...

11/06/2024

Advances in Inflammatory Bowel Disease Network

News

Lupus and IBD Share Microbiome Features

10/18/2024

Jessica Garlewicz ;

Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.

Researchers identified distinct...

10/18/2024

Advances in Inflammatory Bowel Disease Network

News

Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC

10/18/2024

Jessica Garlewicz ;

While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.

While infliximab proved safe and...

10/18/2024

Advances in Inflammatory Bowel Disease Network

News

The Risks of Placebo in IBD Drug Trials

10/18/2024

Rebecca Mashaw ;

Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.

Investigators recommend...

10/18/2024

Advances in Inflammatory Bowel Disease Network

News

Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission

10/08/2024

Jolynn Tumolo ;

Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.

Researchers at the University of...

10/08/2024

Advances in Inflammatory Bowel Disease Network

News

Scores Predict Corticosteroid Failure Risk in Patients With ASUC

10/03/2024

Jolynn Tumolo ;

Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.

Risk of rescue scores that...

10/03/2024

Advances in Inflammatory Bowel Disease Network

News

Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD

10/01/2024

Jolynn Tumolo ;

Early detection and treatment are the keys to reducing risk of progressive disease.

Early detection and treatment...

10/01/2024

Advances in Inflammatory Bowel Disease Network

News

Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use

09/30/2024

Jolynn Tumolo ;

When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.

When used after a first-line...

09/30/2024

Advances in Inflammatory Bowel Disease Network

Latest Podcasts

Video

Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis

10/21/2024

Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.

Dr Long reviews her presentation...

10/21/2024

Advances in Inflammatory Bowel Disease Network

Podcast

IBD Drive Time: Drs James Lewis and Laura Raffals on SPARC

10/21/2024

Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...

Dr Raymond Cross hosts Drs James...

10/21/2024

Advances in Inflammatory Bowel Disease Network

Podcast

Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD

10/11/2024

Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...

Dr Caldera, from the University...

10/11/2024

Advances in Inflammatory Bowel Disease Network

Podcast

IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy

10/07/2024

IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study.

IBD Drive Time Hosts Millie...

10/07/2024

Advances in Inflammatory Bowel Disease Network

Podcast

IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD

09/19/2024

Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.

Dr David Hudesman of NYU-Langone...

09/19/2024

Advances in Inflammatory Bowel Disease Network

Podcast

IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis

09/03/2024

Erin Forster , MD, MPH;

Millie D. Long , MD, MPH;

Raymond Cross , MD;

Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.

Dr Erin Forster of the Medical...

09/03/2024

Advances in Inflammatory Bowel Disease Network

Podcast

IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care

08/05/2024

Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.

Dr Jana Al Hashash from Mayo...

08/05/2024

Advances in Inflammatory Bowel Disease Network

Podcast

Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD

07/25/2024

Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.

Dr Bhat reports on the recent...

07/25/2024

Advances in Inflammatory Bowel Disease Network

Podcast

IBD Drive Time: The Best of DDW, Part 2

07/18/2024

In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.

In part 2 of this podcast,...

07/18/2024

Advances in Inflammatory Bowel Disease Network

Podcast

IBD Drive Time: Best of DDW, Part 1

07/09/2024

In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...

In the first episode of this...

07/09/2024

Advances in Inflammatory Bowel Disease Network

Stephen Hanauer, MD, on the Past, Present, and Future of IBD Pharmacology

Latest News

Latest Podcasts

Specialties

Events

Year Round Education

HMP Global Products